Status:
UNKNOWN
Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19
Lead Sponsor:
Region MidtJylland Denmark
Collaborating Sponsors:
Aarhus University Hospital
Central Jutland Regional Hospital
Conditions:
COVID
Terminal Renal Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
Determination of IgM and IgG antibodies against SARS-CoV-2 in dialysis patients by continous monitoring in the period from March 2020 to december 2020
Detailed Description
Blood samples are collected every 14 days
Eligibility Criteria
Inclusion
- Dialysis
Exclusion
- Not willing to give consent
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04367714
Start Date
March 15 2020
End Date
December 1 2021
Last Update
December 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Godstrup Hospital
Herning, Denmark, 7400